Brighton Pharmaceuticals Inc is categorized under Medical Centers in Durham, NC and active since 2010.
Brighton Pharmaceuticals Inc was established in 2010, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Medical Centers business, which does work in the B2C market, and is classified as a Medical Centers, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact David Preston, Owner at the company’s single location by writing to 1000 Park Forty Plaza, Durham, North Carolina NC 27713 or by phoning (919) 313-6406. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Brighton Pharmaceuticals Inc |
| Contact Person: | David Preston, Owner |
| Address: | 1000 Park Forty Plaza, Durham, North Carolina 27713 |
| Phone Number: | (919) 313-6406 |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Centers |
| SIC Code: | 8011 |
| NAICS Code: | 4242101 |
| Share This Business: |
Brighton Pharmaceuticals Inc was started in 2010 to provide professional Medical Centers under the SIC code 8011 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact David Preston, Owner for inquiries that concern Brighton Pharmaceuticals Inc by calling the company number (919) 313-6406, as your correspondence is most welcome. Additionally, the physical location of the single location of Brighton Pharmaceuticals Inc can be found at the coordinates 35.90512,-78.89359 as well as the street address 1000 Park Forty Plaza in Durham, North Carolina 27713.
For its online presence, you may visit Brighton Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.